Company
Headquarters: Liuzhou, China
Employees: 4,706
CN¥7.03 Billion
CNY as of Jan. 1, 2024
US$988.5 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $63.92 B |
| Cencora, Inc. | $43.41 B |
| Cardinal Health, Inc. | $26.02 B |
| Henry Schein, Inc. | $9.72 B |
| Sinopharm Group Co. Ltd | $8.04 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Guangxi Liuzhou Pharmaceutical Co., Ltd. engages in the distribution and retail of pharmaceutical products in China. The company was founded in 1981 and is based in Liuzhou, China. Guangxi Liuzhou Pharmaceutical Co., Ltd. is a subsidiary of Liuzhou Liangmianzhen Co., Ltd.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Guangxi Liuzhou Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 603368 wb_incandescent